138 related articles for article (PubMed ID: 19375333)
1. Neutral and polyanionic carboranylporphyrazines: synthesis and physico-chemical properties.
Pietrangeli D; Ricciardi G
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S97-S100. PubMed ID: 19375333
[TBL] [Abstract][Full Text] [Related]
2. Conjugates of boron clusters with derivatives of natural chlorin and bacteriochlorin.
Bregadze VI; Sivaev IB; Lobanova IA; Titeev RA; Brittal DI; Grin MA; Mironov AF
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S101-4. PubMed ID: 19447631
[TBL] [Abstract][Full Text] [Related]
3. New approach to incorporation of boron in tumor-seeking molecules.
Sivaev IB; Semioshkin AA; Bregadze VI
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S91-3. PubMed ID: 19375335
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of a novel liposome containing BPA-peptide conjugate for BNCT.
Shirakawa M; Yamamto T; Nakai K; Aburai K; Kawatobi S; Tsurubuchi T; Yamamoto Y; Yokoyama Y; Okuno H; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S88-90. PubMed ID: 19446462
[TBL] [Abstract][Full Text] [Related]
5. Water-soluble carboranyl-phthalocyanines for BNCT. Synthesis, characterization, and in vitro tests of the Zn(II)-nido-carboranyl-hexylthiophthalocyanine.
Pietrangeli D; Rosa A; Pepe A; Altieri S; Bortolussi S; Postuma I; Protti N; Ferrari C; Cansolino L; Clerici AM; Viola E; Donzello MP; Ricciardi G
Dalton Trans; 2015 Jun; 44(24):11021-8. PubMed ID: 25995094
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel carboranylchlorins with dual application in boron neutron capture therapy (BNCT) and photodynamic therapy (PDT).
Luguya R; Fronczek FR; Smith KM; Vicente MG
Appl Radiat Isot; 2004 Nov; 61(5):1117-23. PubMed ID: 15308202
[TBL] [Abstract][Full Text] [Related]
7. Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy.
Hiramatsu R; Kawabata S; Tanaka H; Sakurai Y; Suzuki M; Ono K; Miyatake S; Kuroiwa T; Hao E; Vicente MG
J Pharm Sci; 2015 Mar; 104(3):962-70. PubMed ID: 25546823
[TBL] [Abstract][Full Text] [Related]
8. Strategies for the design and synthesis of boronated nucleic acid and protein components as potential delivery agents for neutron capture therapy.
Wyzlic IM; Tjarks W; Soloway AH; Anisuzzaman AK; Rong FG; Barth RF
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1203-13. PubMed ID: 8175406
[TBL] [Abstract][Full Text] [Related]
9. Correction: The potential role of borophene as a radiosensitizer in boron neutron capture therapy (BNCT) and particle therapy (PT).
Qi P; Chen Q; Tu D; Yao S; Zhang Y; Wang J; Xie C; Pan C; Peng H
Biomater Sci; 2021 Apr; 9(7):2743-2744. PubMed ID: 33861289
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy.
Renner MW; Miura M; Easson MW; Vicente MG
Anticancer Agents Med Chem; 2006 Mar; 6(2):145-57. PubMed ID: 16529537
[TBL] [Abstract][Full Text] [Related]
11. Boronated thymidine analogues for boron neutron capture therapy.
Thirumamagal BT; Johnsamuel J; Cosquer GY; Byun Y; Yan J; Narayanasamy S; Tjarks W; Barth RF; Al-Madhoun AS; Eriksson S
Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):861-6. PubMed ID: 16901817
[TBL] [Abstract][Full Text] [Related]
12. Development of boron nanocapsules for neutron capture therapy.
Nakamura H; Ueno M; Ban HS; Nakai K; Tsuruta K; Kaneda Y; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S84-7. PubMed ID: 19406654
[TBL] [Abstract][Full Text] [Related]
13. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
14. Intracellular uptake of a new boronated porphyrin EC032.
Tsurubuchi T; Yamamoto T; Nakai K; Zaboronok A; Yoshida F; Miyakawa M; Shirakawa M; Yamamoto Y; Matsuda M; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S94-6. PubMed ID: 19410469
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy.
Byun Y; Yan J; Al-Madhoun AS; Johnsamuel J; Yang W; Barth RF; Eriksson S; Tjarks W
J Med Chem; 2005 Feb; 48(4):1188-98. PubMed ID: 15715485
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of a carboranyl-tetrabenzoporphyrin.
Ongayi O; Gottumukkala V; Fronczek FR; Vicente MG
Bioorg Med Chem Lett; 2005 Mar; 15(6):1665-8. PubMed ID: 15745818
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of carborane-containing porphyrins as tumour targeting agents for boron neutron capture therapy.
Miura M; Micca PL; Fisher CD; Gordon CR; Heinrichs JC; Slatkin DN
Br J Radiol; 1998 Jul; 71(847):773-81. PubMed ID: 9771389
[TBL] [Abstract][Full Text] [Related]
18. Novel boronated derivatives of 5,10,15,20-tetraphenylporphyrin: synthesis and toxicity for drug-resistant tumor cells.
Ol'shevskaya VA; Zaitsev AV; Luzgina VN; Kondratieva TT; Ivanov OG; Kononova EG; Petrovskii PV; Mironov AF; Kalinin VN; Hofmann J; Shtil AA
Bioorg Med Chem; 2006 Jan; 14(1):109-20. PubMed ID: 16185886
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy.
Lee JD; Ueno M; Miyajima Y; Nakamura H
Org Lett; 2007 Jan; 9(2):323-6. PubMed ID: 17217295
[TBL] [Abstract][Full Text] [Related]
20. Improved pharmaceutical stability of a boronphenylalanine mannitol formulation for boron neutron capture therapy.
Halbert G; Elliott M; Ford S; Dick L; Schmidt E
Eur J Pharm Sci; 2013 Mar; 48(4-5):735-9. PubMed ID: 23354152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
